Spend $99, get free U.S. shipping*
Tariff now required on U.S. shipments. Learn more »
Tel: 1-866-456-3768 Fax: 1-866-544-8993
For visual reference only; actual product may vary
For visual reference only; actual product may vary
Anoro Ellipta is a once-daily prescription inhaler for the long-term treatment of Chronic Obstructive Pulmonary Disease (COPD) in adults. It combines two bronchodilators to relax airway muscles, making it easier to breathe. This is a maintenance therapy, not a rescue inhaler for sudden breathing problems.
| Anoro Ellipta Brand | 55/22mcg 1 Inhaler |
-
|
Our price: $95.00 |
Anoro Ellipta is a prescription maintenance inhaler used once-daily to improve symptoms in adults with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. This medication combines two active ingredients, umeclidinium and vilanterol, to help relax the muscles around the airways in your lungs, making it easier to breathe. It is intended for long-term, regular use and is not a rescue inhaler, meaning it should not be used for sudden breathing problems or acute bronchospasms.
Anoro Ellipta works by combining two different types of bronchodilators that open up the airways to improve breathing. The first active ingredient, umeclidinium, is a long-acting muscarinic antagonist (LAMA). It works by blocking receptors that cause the muscles around your airways to tighten. The second ingredient, vilanterol, is a long-acting beta2-adrenergic agonist (LABA). It works by stimulating different receptors that signal these same muscles to relax. Together, they provide 24-hour relief by keeping the airways open, reducing the likelihood of COPD flare-ups and making daily activities more manageable.
Anoro Ellipta is designed for adults who have been diagnosed with COPD and require ongoing, long-term management of their symptoms. This includes individuals suffering from the effects of emphysema or chronic bronchitis, such as persistent coughing, wheezing, and shortness of breath. Because it is a maintenance therapy, it is suitable for patients who need consistent, daily treatment to control their condition and prevent exacerbations. Anoro Ellipta is not indicated for the treatment of asthma and should not be used as a primary treatment in patients with asthma.
The standard dosage for Anoro Ellipta is one inhalation by mouth once a day, and it is crucial to use it at the same time each day to maintain its effectiveness. To administer a dose, you will slide the cover of the Ellipta inhaler open until it clicks, exposing the mouthpiece. Without blocking the air vent, you should breathe out fully, put the mouthpiece to your lips, and take one long, steady, deep breath in. Hold your breath for 3-4 seconds, then breathe out slowly. Close the inhaler. You should not take more than one inhalation every 24 hours.
The most common side effects associated with Anoro Ellipta include sore throat, sinus infections, runny nose, cough, and constipation. Some users may also experience diarrhea, pain in the arms or legs, muscle spasms, neck pain, and chest pain. More serious side effects can occur, though they are less common. These include paradoxical bronchospasm (sudden breathing difficulty after use), heart problems like increased blood pressure or rapid heart rate, new or worsening eye problems like narrow-angle glaucoma, and urinary retention. Seek immediate medical attention if you experience an allergic reaction, such as a rash, hives, or swelling of the face, mouth, and tongue.
Choosing IsraelPharm for your Anoro Ellipta prescription provides an affordable and reliable way to manage your COPD treatment. We are committed to making essential medications accessible by sourcing them from reputable suppliers at competitive prices, passing the savings directly to you. Our platform is user-friendly and secure, ensuring a private and straightforward ordering process. With a team of licensed pharmacists available to answer your questions and a dedicated customer support staff, IsraelPharm is a trusted partner in your long-term health management, delivering your medication right to your door.
The most common side effects of Anoro Ellipta can include:
More serious side effects may include new or worsening eye problems (like acute narrow-angle glaucoma), urinary retention, and cardiovascular effects. If you experience any signs of a serious allergic reaction, such as swelling of the face or tongue, or sudden breathing problems after inhaling, seek medical help immediately. For a complete list, consult the patient information leaflet.
Anoro Ellipta is an inhaler used as a long-term, once-daily maintenance treatment to improve breathing in adults with chronic obstructive pulmonary disease (COPD), including:
It is not indicated for the relief of acute bronchospasm or for the treatment of asthma.
Anoro Ellipta begins to work within about 15 minutes of inhalation, helping to make breathing easier. However, it is a long-term maintenance medication, and its full effect is designed to last for 24 hours. You may not feel an immediate, dramatic change, but consistent daily use helps manage COPD symptoms over time. It is not meant for immediate relief of sudden breathing problems.
No, Anoro Ellipta is not a rescue inhaler and should not be used for sudden breathing problems or a COPD flare-up. It is a maintenance medication that works over 24 hours. You should always have a separate rescue inhaler, such as albuterol, prescribed by your doctor for immediate relief of acute symptoms. If your rescue inhaler isn't working, seek medical attention.
If you miss a dose of Anoro Ellipta, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular once-daily schedule. Do not take two doses at the same time or extra doses to make up for the missed one, as this can increase the risk of side effects.
Anoro Ellipta is not approved for the treatment of asthma. The safety and effectiveness of using umeclidinium/vilanterol in patients with asthma have not been established. Using LABA medicines like vilanterol without an inhaled corticosteroid (ICS) for asthma can increase the risk of serious complications. Always consult your doctor for appropriate asthma treatment.
Store your Anoro Ellipta inhaler at room temperature, away from direct heat, sunlight, and moisture. Keep it in the sealed foil tray it came in until you are ready for its first use, and discard it 6 weeks after opening the tray or when the dose counter reads '0', whichever comes first. Keep the cover closed during storage and keep it out of reach of children.
Unlike inhaled corticosteroids, rinsing your mouth is not strictly required after using Anoro Ellipta to prevent oral thrush. However, some people choose to rinse with water and spit it out after inhalation to reduce the chance of side effects like dry mouth or throat irritation. This can be a good habit to maintain, but it is not mandatory.
Anoro Ellipta contains two active ingredients: umeclidinium and vilanterol. Umeclidinium is an anticholinergic (also known as a LAMA) that stops muscles around the airways from tightening. Vilanterol is a long-acting beta2-adrenergic agonist (LABA) that helps the same muscles relax. Together, they work to keep airways open for easier breathing in people with COPD.
Dry mouth is a possible side effect of Anoro Ellipta, primarily due to the anticholinergic effects of the umeclidinium component. This is not uncommon with this class of medication. Staying hydrated by drinking plenty of water, chewing sugar-free gum, or using saliva substitutes can help manage this symptom. If it becomes bothersome or severe, discuss it with your healthcare provider.
Yes, Anoro Ellipta can potentially cause cardiovascular side effects. The vilanterol component can lead to a rapid heart rate (tachycardia), increased blood pressure, and palpitations in some individuals. Patients with pre-existing heart conditions should discuss the risks with their doctor before starting this medication. Seek medical advice if you experience chest pain or a racing heart while using it.
The Anoro Ellipta inhaler has a dose counter on the front that shows you how many doses are left. The counter will count down by one each time you open the cover. When fewer than 10 doses are remaining, the number will appear in red as a reminder to get a refill. The inhaler is empty and should be discarded when the counter shows '0'.
Anoro Ellipta should be used with caution in patients with narrow-angle glaucoma. The umeclidinium in Anoro can increase pressure inside the eye, potentially worsening this condition. Inform your doctor if you have a history of glaucoma. They will help you weigh the benefits against the risks. Report any eye pain, blurred vision, or halos to your doctor immediately.
Once-daily inhalation means you should use your Anoro Ellipta inhaler only one time every 24 hours. It's important to take your dose at the same time each day, either morning or evening, to maintain a consistent level of medication in your body. This regular schedule helps control your COPD symptoms effectively throughout the day and night. Do not use it more than once a day.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days
IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.
Struggling with acid reflux? Sarah Ryan shares her personal experience using Nexium for GERD and how to find affordable brand-name relief through a licensed pharmacy.
Polycystic Metabolic Ovarian Syndrome (PMOS) is the new clinical name for the condition long known as Polycystic Ovary Syndrome (PCOS). The change reflects a deeper scientific understanding that insulin resistance and metabolic dysfunction sit at
